Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 4/20 | 0.50 |
| ▸ | NPY4R | P50391 | 4/20 | 0.50 |
| ▸ | NPY1R | P25929 | 3/20 | 0.50 |
| ▸ | TFPI | P10646 | 1/20 | 0.49 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.49 |
| ▸ | NPY2R | P49146 | 1/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18556709 | 0.89 | OPRD1 (0.51) | TFPIQRFPROPRD1OPRM1OPRK1 | |
| SCHEMBL30924733 | 0.85 | TFPI (0.56) | TFPIQRFPROPRL1 | |
| SCHEMBL30924743 | 0.85 | TFPI (0.56) | NPY5RNPY4RNPY1RTFPINPY2R | |
| SCHEMBL24713147 | 0.85 | NPY4R (0.58) | NPY5RNPY4RNPY1RQRFPRNPY2R | |
| SCHEMBL24713048 | 0.84 | QRFPR (0.53) | NPY5RNPY4RNPY1RQRFPRNPY2R | |
| SCHEMBL24488464 | 0.84 | NPY4R (0.49) | NPY5RNPY4RNPY1RQRFPRNPY2R | |
| SCHEMBL24158319 | 0.84 | TFPI (0.48) | NPY5RNPY4RNPY1RTFPIQRFPR | |
| SCHEMBL30688407 | 0.83 | NPY4R (0.57) | NPY5RNPY4RNPY1RTFPINPY2R | |
| SCHEMBL31563618 | 0.83 | NPY4R (0.59) | NPY5RNPY4RNPY1RNPY2ROPRD1 | |
| SCHEMBL10786338 | 0.83 | OPRD1 (0.64) | OPRD1OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170145056-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | PALATIN TECHNOLOGIES INC (US) | 2017-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170145056-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | MC1R, MC5R, MC3R | NPY5R 6/4885NPY4R 9/4885NPY1R 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.